Archives: “Archives”

Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network

A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells

A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus erythematosus patients

Association of autoantibody concentrations and trajectories with lupus nephritis histologic features and treatment response

Associations between blood DNA methylation and histopathologic features in lupus nephritis

Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis

Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells

Yale Researchers Identify Two New Therapeutic Targets for Fibrotic Diseases Like Scleroderma and Lupus

Two Yale studies have identified a promising new antibody therapy and a previously unknown signaling pathway as potential treatments for fibrotic autoimmune diseases including scleroderma, lupus, and graft-versus-host disease.

Colton Consortium Sponsors 2025 FASEB Autoimmunity Conference

The Colton Consortium sponsored the 2025 FASEB Autoimmunity Conference in Niagara Falls, a leading international forum dedicated to advancing autoimmune research and fostering collaboration among scientists and clinicians worldwide.

Yale’s Colton Center for Autoimmunity Awards Nearly $1M to Nine Research Projects in 2025

Yale's Colton Center for Autoimmunity has selected nine researchers for nearly $1 million in 2025 funding, backing projects that apply AI, nanoparticles, and novel biologics to autoimmune disease.